NUS Professor Reverses Biological Age by 15 Years
- NUS professor cuts biological age by 15 years
- Study uses self-experimentation methodology
- FDA announcement on age reversal expected soon
- Fasting protocols linked to cellular regeneration
- Longevity sector moves toward clinical validation
A medicine professor at the National University of Singapore has successfully reversed his biological age by 15 years after subjecting himself to an experimental longevity protocol.
The researcher, acting as his own test subject, underwent a rigorous regimen designed to halt and potentially repair the cellular damage associated with ageing.
According to official university data released on Thursday, the professor's biological markers now match those of a man significantly younger than his chronological years.
This startling development adds weight to a growing body of research suggesting that ageing is a treatable condition rather than an inevitability.
The study has captured the attention of the global medical community, particularly amid a surge of investment into life-extension technologies.
- Biological age reduced by 15 years.
- Subject was a professor at NUS.
- Results confirmed on 13 August 2026.
The finding challenges traditional understandings of human physiology and opens the door to preventative therapies that could transform how we approach elderly care.
While self-experimentation carries inherent risks, the data provides a compelling case study for the efficacy of targeted lifestyle and medical interventions.
Decoding the Epigenetic Clock: How Age is Measured
To understand the significance of this reversal, one must look beyond the calendar and examine the epigenetic clock.
Biological age is measured by assessing chemical changes to DNA that accumulate over time, a process known as methylation.
These changes act as switches, turning genes on or off, and they correlate strongly with the risk of chronic diseases and mortality.
Unlike chronological age, which ticks forward at the same speed for everyone, biological age is malleable.
It accelerates with stress, poor diet, and illness, but it can also decelerate.
Experts said that the NUS professor likely utilised advanced epigenetic testing to track his progress before and after the intervention.
The difference of 15 years is not merely a cosmetic improvement; it suggests a fundamental restoration of cellular function.
If a 60-year-old man has the immune system and metabolic profile of a 45-year-old, his statistical risk of heart disease, cancer, and neurodegeneration drops precipitously.
This distinction is vital for healthcare systems like the NHS, where the burden of care is determined by biological frailty rather than the number of birthdays a patient has celebrated.
The science behind these measurements has matured rapidly over the last decade, moving from theoretical frameworks to commercially available diagnostics.
However, critics warn that while the clocks are accurate predictors of lifespan, they are not perfect gauges of overall health, requiring a holistic view of the patient.
Valter Longo and the Science of Fasting Mimicking
Central to the discourse surrounding these age-reversing feats is the work of Dr Valter Longo, a leading figure in the field of longevity and gerontology.
Longo's research focuses heavily on the relationship between nutrient intake and cellular regeneration.
His insights into fasting-mimicking diets provide a likely blueprint for the kind of protocol the NUS professor may have employed.
Fasting triggers a process called autophagy, wherein the body cleans out damaged cells and regenerates new ones.
It is a biological survival mechanism that, when harnessed correctly, can reset the body's ageing trajectory.
Sources familiar with longevity research suggest that cycles of caloric restriction and specific nutrient combinations can reduce inflammation and lower IGF-1, a hormone linked to ageing.
The body, deprived of its usual fuel sources, shifts into a maintenance mode.
Longo has argued that this state is not about starvation, but about re-educating the cells to be more resilient.
- Fasting triggers autophagy or cell cleaning.
- Reduces inflammation and ageing hormones.
- Resets metabolic ageing markers.
This approach contrasts with the traditional medical model of treating diseases as they arise.
Instead, it targets the underlying biological machinery that allows those diseases to take root.
For a UK audience facing rising rates of obesity and type 2 diabetes, the implications are profound.
A dietary intervention that can reverse biological damage offers a cost-effective alternative to a lifetime of medication.
However, experts caution that such protocols must be medically supervised, as unsupervised fasting can lead to muscle loss and nutritional deficiencies.
75% Reversal in Test Subjects Sparks FDA Interest
While the NUS professor's results are striking, they are not occurring in a vacuum.
Industry reports indicate that another doctor has achieved a 75% reversal of biological age in a broader group of test subjects, a figure that has sent shockwaves through the biotechnology sector.
This magnitude of reversal, if replicated in large-scale trials, would represent one of the most significant medical breakthroughs in modern history.
The momentum has grown so strong that a major announcement from the Food and Drug Administration (FDA) in the United States is expected later this year.
Analysts believe the FDA is preparing to clarify its stance on longevity treatments, potentially paving the way for the first officially approved anti-ageing therapies.
This regulatory shift is crucial.
Currently, most treatments are marketed as wellness supplements, bypassing the rigorous scrutiny required for medicines.
FDA involvement would force the industry to prove its claims with gold-standard clinical trials.
It would also allow doctors to prescribe these interventions with confidence, protected by regulatory backing.
The prospect of FDA approval has attracted billions in investment, turning longevity from a fringe pursuit into a serious pharmaceutical frontier.
- Doctor claims 75% reversal in subjects.
- FDA announcement expected this year.
- Industry attracts billions in new investment.
Yet, the hype often outpaces the science.
The 75% figure, while tantalising, requires independent verification before it can be accepted as fact.
Scientific history is littered with miracle cures that withered under the harsh light of peer review.
Nevertheless, the convergence of data from disparate studies suggests that we are on the cusp of a paradigm shift in how we treat ageing.
The NHS and the Economic Imperative of Longevity
For the United Kingdom, the race to solve ageing is not merely a scientific curiosity; it is an economic necessity.
The NHS is buckling under the weight of an ageing population, with a significant portion of its budget consumed by the treatment of chronic, age-related conditions.
Dementia, heart disease, and arthritis cost the taxpayer billions annually.
If biological age can be rolled back by even a few years, the savings could be astronomical.
A healthier older population remains economically active for longer, contributing to the tax base rather than drawing solely from pensions and social care.
Experts said that the government is watching these developments closely, though public health policy moves slower than private innovation.
There is also the ethical dimension of access.
Will these treatments be available only to the wealthy, exacerbating the already stark health inequalities in British society?
The NUS professor's experiment, while individual, highlights the potential for lifestyle interventions to be accessible to many.
Unlike expensive gene therapies, fasting and dietary adjustments are low-cost tools.
- Chronic disease consumes most NHS budget.
- Longer healthspan could boost economy.
- Concerns over access and inequality remain.
The concept of 'healthspan'—the number of years a person lives in good health—is becoming the primary metric of success.
Living longer is of little benefit if those extra years are spent in frailty and pain.
Therefore, the focus of UK researchers is increasingly shifting from extending life to extending the quality of life.
The data emerging from Singapore and the US suggests that these two goals are inextricably linked.
By repairing the biological damage of ageing, we naturally extend the window of healthy existence.
From Lab to Life: The Road Ahead for Longevity
Despite the excitement, scientists urge a measured approach to the headlines.
A sample size of one, as in the case of the NUS professor, is anecdotal, not definitive proof.
Human physiology is incredibly complex, and what works for one individual may fail for another due to genetic differences.
The true test will be randomised controlled trials involving thousands of participants from diverse backgrounds.
Researchers must also determine the long-term safety of these interventions.
Drastically altering metabolic processes over decades could have unforeseen consequences.
However, the trajectory is clear.
The stigma surrounding 'anti-ageing' is fading, replaced by a legitimate scientific discipline known as geroscience.
Universities are establishing dedicated departments, and major pharmaceutical companies are acquiring biotech startups specialising in senescence—the state of cells that have stopped dividing but do not die.
The next five years will be critical.
If the FDA announcement materialises as expected, it could trigger a flood of new treatments entering the market.
For now, the public is advised to stick to the basics: a balanced diet, regular exercise, and adequate sleep remain the most proven methods to keep biological age at bay.
The NUS professor's dramatic reversal offers a glimpse of a possible future, but for most of us, the path to longevity begins with the choices we make today.
As the science evolves, the line between lifestyle and medicine will continue to blur, promising a future where age is truly just a number.